1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Global Radiofrequency Ablation Devices Market Assessment & Forecast: 2015-2019

The new report “Global Radiofrequency Ablation Devices Market Assessment & Forecast: 2015-2019” by Spearhead Acuity Business Research & Consulting Group reveals that North America lead the global radiofrequency ablation devices market with a share of 45.3% in 2014 that translated into revenues worth US$ 1,421.8 million.

North America leads the market primarily since the technology has had early commercial success in the region. Greater purchase power and availability to training and other modules enabled faster market penetration and awareness of RF ablation over the years. Today the RF technology is mature and well known among medical communities across the world and thus the growth rate for each region does not vary greatly from one another. Rising incidence of tumors, arrhythmia and chronic pain across the world continues to ensure that the market grows steadily. The American Academy of Pain Medicine and American Society of Anesthesiologists suggest that chronic pain affects over 60 million people across the world. Pain is experienced due to trauma, sensory or nervous disorders, cancer, aging and a host of other reasons making it one of the most lucrative segments for introducing medical device for treatment.

This report covers over 25 notable device manufacturers and highlights key players in each application segment while putting special emphasis on leaders of the RF ablation devices market such as Medtronic Inc (Covidien), Johnson & Johnson (Biosense Webster and DePuy Mitek), Boston Scientific, Stryker, St. Jude Medical, Arthrex and Haylard Health (former part of Kimberly Clark). Higher awareness of rarer applications such as endometrial ablation has also supplemented the growth of the RF ablation devices market in North America and Europe. Europe has shown particular resilience and leadership in approving renal denervation systems where the US FDA has remained unmovingly skeptical of the clinical outcomes. Nevertheless, the presence of most major RF technology companies in these regions and several new entrants in the market will ensure that these geographies continue to hold the controlling share. Growth is expected along with greater adoption of procedure planning and mapping systems such as Topera’s RhythmView and FIRMap that constitute capital equipment. A large number of catheter manufacturers are entering the market and provide catheters that are compatible with existing EP equipment.

Radiofrequency ablation was first applied in the medical field in 1930s when Krischner treated trigeminal neuralgia with thermocoagulation of the gassaerian ganglion. In the late 1950s the first commercial radiofrequency (RF) machine became available from Cosman and Aronow. Radiofrequency ablation uses RF waves to convert electromagnetic energy into heat energy which is dissipated into the tissue by an electrode/catheter/probe/ needle. In the following 70-80 years, RF ablation has found incredible applications in the treatment of various diseases and disorders that have already been covered in the report above. A large number of players are currently competing in the RF ablation market in different applications. Most players are inclined to strengthen existing portfolio of RF devices through distribution and acquisitions. Top RF device manufacturers extend their portfolio to address multiple applications such as tumor ablation, pain management together or focus on building portfolio of substitute products that address one medical condition. For e.g. St Jude Medical’s EP portfolio addresses arrhythmia by offering cardiac ablation and pacemakers. It addresses the pain management market through devices such as denervation system and neuromodulation for chronic pain. The market for devices that target a large population such as cardiac ablation, general surgery and cosmetology are now getting extremely crowded and it is expected that within a few years the overall market will become highly fragmented with private players that are unregulated and who have strong local dominance.

Table Of Contents

Global Radiofrequency Ablation Devices Market Assessment and Forecast: 2015-2019
Chapter 1 Preface
1.1 Research Scope
1.1.1 Market Segmentation
1.1.2 Postulations
1.2 Methodology of Research
1.2.1 Companies covered in this report
Chapter 2 Precis
2.1 Market Inferences
Chapter 3 Market Dynamics
3.1 Market Drivers
3.1.1 Incidence of ineffectiveness of antiarrhythmic drugs is becoming a positive stimulus for treatment by RF ablation
3.1.2 Minimally invasive out-patient procedure
3.1.3 Highly mature and clinically proven technology with diverse applications
3.2 Market Inhibitors
3.2.1 Rising competition from substitute treatment methods such as cryoablation and microwave ablation
3.2.2 Renal denervation's steep downslide to restrict and contract market expectations from radiofrequency ablation technologies
3.3 Opportunities
3.3.1 New life for RF ablation devices for hypertension
3.3.2 Opportunities in emerging markets
3.3.3 MRI Compatible Catheters
Chapter 4 Radiofrequency Ablation Devices - Global Market Size Assessment, by Applications, Forecast: 2015 - 2019
4.1 Introduction
4.2 Radiofrequency Ablation Devices Market, by Tumor Management, US$ Mn (2013 - 2019)
4.3 Radiofrequency Ablation Devices Market, by Cardiac Rhythm Management, US$ Mn (2013 - 2019)
4.4 Radiofrequency Ablation Devices Market, by General Surgery, US$ Mn (2013 - 2019)
4.5 Radiofrequency Ablation Devices Market, by Pain Management, US$ Mn (2013 - 2019)
4.6 Radiofrequency Ablation Devices Market, by Cosmetology, US$ Mn (2013 - 2019)
4.7 Radiofrequency Ablation Devices Market, by Hypertension Management, US$ Mn (2013 - 2019)
4.8 Radiofrequency Ablation Devices Market, by Gynecology, US$ Mn (2013 - 2019)
4.9 Radiofrequency Ablation Devices Market, by Other Applications, US$ Mn (2013 - 2019)
Chapter 5 Radiofrequency Ablation Devices - Global Market Size Assessment, by Products, Forecast: 2015 - 2019
5.1 Introduction
5.2 Radiofrequency Generators Market, US$ Mn (2013 - 2019)
5.3 Radiofrequency Catheters and Probes Market, US$ Mn (2013 - 2019)
5.4 Radiofrequency Disposables Market, US$ Mn (2013 - 2019)
5.5 Radiofrequency Special Capital Equipment Market, US$ Mn (2013 - 2019)
Chapter 6 Radiofrequency Ablation Devices - Global Market Size Assessment, by Geography, Forecast: 2015 - 2019
6.1 North America Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
6.2 Europe Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
6.3 Asia-Pacific Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
6.4 Latin America Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
6.5 Middle-East Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
6.6 Africa Radiofrequency Ablation Devices Market, US$ Mn (2013 - 2019)
Chapter 7 Key Players Analysis: Radiofrequency Ablation Devices Market Share, 2014 (%)
7.1 Key Players Market Share: Radiofrequency Ablation Devices Market, 2014 (%)
7.2 Global Radiofrequency Ablation Devices Market: Recent Developments 2013-2015
7.2.1 Mergers and Acquisitions
7.2.2 Joint Ventures, Expansion and Collaborations
7.2.3 New Product Launches and Approvals
7.3 Competitive Landscape: Strategies
Chapter 8 Epilogue


List of Figures

FIG. 1 Market Segmentation: Global Radiofrequency Ablation Devices Market
FIG. 2 Research Methodology: Global Radiofrequency Ablation Devices Market Assessment
FIG. 3 Global Raadiofrequency Ablation Devices Market Share, by Geography 2014 and 2019 (% Share - US$ Million)
FIG. 4 Radiofrequency Ablation Devices - Global Market Share, by Applications 2014 and 2019 (% Share - US$ Million)
FIG. 5 Global Radiofrequency Ablation Devices Market by Tumor Management 2013 - 2019 (US$ Million)
FIG. 6 Global Radiofrequency Ablation Devices Market for Cardiac Rhythm Management 2013 - 2019 (US$ Million)
FIG. 7 Global Radiofrequency Ablation Devices Market for General Surgery 2013 - 2019 (US$ Million)
FIG. 8 Global Radiofrequency Ablation Devices Market for Pain Management 2013 - 2019 (US$ Million)
FIG. 9 Global Radiofrequency Ablation Devices Market for Cosmetology 2013 - 2019 (US$ Million)
FIG. 10 Global Radiofrequency Ablation Devices Market for Hypertension Management 2013 - 2019 (US$ Million)
FIG. 11 Global Radiofrequency Ablation Devices Market for Gynecology 2013 - 2019 (US$ Million)
FIG. 12 Global Radiofrequency Ablation Devices Market for Other Applications 2013 - 2019 (US$ Million)
FIG. 13 Global Radiofrequency Ablation Devices Market Share, by Products 2014 - 2019 (% Share US$ Millions)
FIG. 14 Global Radiofrequency Generators Market 2013 - 2019 (US$ Million)
FIG. 15 Global Radiofrequency Catheters and Probes Market 2013 - 2019 (US$ Million)
FIG. 16 Global Radiofrequency Disposables Market 2013 - 2019 (US$ Million)
FIG. 17 Global Radiofrequency Ablation Special Capital Equipment Market 2013 - 2019 (US$ Million)
FIG. 18 Key Players Market Share: Radiofrequency Ablation Devices Market, 2014 (%)
FIG. 19 Ablation Devices Market, by Energy Type 2014 (% Share US$ Millions)



List of Tables

TABLE 1 List of companies covered in this report
TABLE 2 Global Radiofrequency Ablation Devices Market, by Geography, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 3 North America Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 4 Europe Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 5 Asia-Pacific Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 6 Latin America Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 7 Middle-East Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)
TABLE 8 Africa Radiofrequency Ablation Devices Market, by Products, 2013 - 2019 (US$ Mn) (CAGR: 2015 - 2019)





Companies Mentioned
Medtronic Inc (Covidien PLC), Boston Scientific Corporation, St. Jude Medical, Stryker Corporation, AngioDynamics, AtriCure Inc., Sutter Medizintechnik GmbH, Diros Technology, Arthrex, Haylard Health Inc., Cosman Medical Inc., Stockert, Johnson and Johnson (Biosense Webster and DePuy Mitek), Fcare Systems, Hologic (Novasure), Biotronik, Stryker, Topera (Abbott Laboratories), etc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Tumor Ablation Market by Technology, Mode of Treatment, Application - Global Forecast 2021

Tumor Ablation Market by Technology, Mode of Treatment, Application - Global Forecast 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global tumor ablation market is estimated to register a high CAGR of 12.5% during 2016-2021, and is expected to be valued at ~USD 580.1 million in 2021. Although mature markets (North America and Europe) ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.